135 related articles for article (PubMed ID: 34859411)
1. Detection of Circulating and Tissue Myeloid-Derived Suppressor Cells (MDSC) by Flow Cytometry.
Sanchez-Pino MD
Methods Mol Biol; 2022; 2422():247-261. PubMed ID: 34859411
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
[TBL] [Abstract][Full Text] [Related]
3. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
Nelson N; Szekeres K; Cooper D; Ghansah T
J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
[TBL] [Abstract][Full Text] [Related]
5. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
Heuvers ME; Muskens F; Bezemer K; Lambers M; Dingemans AC; Groen HJM; Smit EF; Hoogsteden HC; Hegmans JPJJ; Aerts JGJV
Lung Cancer; 2013 Sep; 81(3):468-474. PubMed ID: 23850196
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
7. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.
Singh A; Rieber N
Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
[TBL] [Abstract][Full Text] [Related]
10. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
11. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
Sangaletti S; Talarico G; Chiodoni C; Cappetti B; Botti L; Portararo P; Gulino A; Consonni FM; Sica A; Randon G; Di Nicola M; Tripodo C; Colombo MP
Front Immunol; 2019; 10():1369. PubMed ID: 31281314
[TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.
Wang Z; Zheng G; Li G; Wang M; Ma Z; Li H; Wang XY; Yi H
J Cell Mol Med; 2020 Dec; 24(23):13703-13714. PubMed ID: 33094923
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
14. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.
Beliakova-Bethell N; Maruthai K; Xu R; Salvador LCM; Garg A
Front Immunol; 2022; 13():894543. PubMed ID: 35812392
[TBL] [Abstract][Full Text] [Related]
15. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
[TBL] [Abstract][Full Text] [Related]
16. Detection of myeloid-derived suppressor cells by flow cytometry.
Liu T; Rosek A; Gonzalez De Los Santos F; Phan SH
Methods Cell Biol; 2024; 184():1-15. PubMed ID: 38555150
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.
Argyropoulos KV; Pulitzer M; Perez S; Korkolopoulou P; Angelopoulou M; Baxevanis C; Palomba ML; Siakantaris M
Clin Transl Oncol; 2020 Jul; 22(7):1059-1066. PubMed ID: 31696413
[TBL] [Abstract][Full Text] [Related]
18. Isolation of Human Circulating Myeloid-Derived Suppressor Cells and Analysis of Their Immunosuppressive Activity.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():43-56. PubMed ID: 33237539
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Antimicrobial Activity of Monocytic Myeloid-Derived Suppressor Cells in Infection with Mycobacterium tuberculosis and Human Immunodeficiency Virus.
Garg A
Methods Mol Biol; 2021; 2236():115-127. PubMed ID: 33237545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
